MedPath

Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)

Not Applicable
Active, not recruiting
Conditions
Aortic Valve Stenosis
Interventions
Device: SAPIEN 3 THV
Biological: Optimal Heart Failure Therapy
Registration Number
NCT02661451
Lead Sponsor
Cardiovascular Research Foundation, New York
Brief Summary

The objective of this study is to determine the safety and efficacy of transcatheter aortic valve replacement (TAVR) via a transfemoral approach in HF patients with moderate AS as compared with OHFT.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
178
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TAVR (with SAPIEN 3 THV) and OHFTOptimal Heart Failure TherapyTranscatheter heart valve and Optimal Heart Failure Therapy
TAVR (with SAPIEN 3 THV) and OHFTSAPIEN 3 THVTranscatheter heart valve and Optimal Heart Failure Therapy
OHFTOptimal Heart Failure TherapyOptimal Heart Failure Therapy
Primary Outcome Measures
NameTimeMethod
Disabling Stroke12 months

Hierarchical occurrence within efficacy assessment time interval (EATI) of:

Hospitalizations related to heart failure, symptomatic aortic valve disease or non-disabling stroke -or - Clinically significant worsening of heart failure (heart failure hospitalization equivalent).12 months

Hierarchical occurrence within efficacy assessment time interval (EATI) of:

Change in KCCQ relative to baseline12 months

Hierarchical occurrence within efficacy assessment time interval (EATI) of:

All-Cause Death12 months

Hierarchical occurrence within efficacy assessment time interval (EATI) of:

Secondary Outcome Measures
NameTimeMethod
-All-cause death within EATI12 month

-All-cause death within EATI

MACCE defined as the composite of all-cause death, all stroke, and hospitalizations for heart failure or symptomatic aortic valve disease or clinically significant worsening of heart failure within EATI. Hierarchical occurrence within EATI of:12 month

1. All-cause death

2. Disabling stroke

3. Hospitalizations related to heart failure, symptomatic aortic valve disease or non-disabling stroke or clinically significant worsening of heart failure (heart failure event)

Trial Locations

Locations (51)

HealthEast Medical Research Institute

🇺🇸

Saint Paul, Minnesota, United States

Advocate Christ Hospital

🇺🇸

Chicago, Illinois, United States

Chandler Regional Medical Center

🇺🇸

Chandler, Arizona, United States

UCSD/Sulpizio Cardiovascular Center

🇺🇸

La Jolla, California, United States

University of Southern California - Los Angeles

🇺🇸

Los Angeles, California, United States

UCLA Medical Center

🇺🇸

Los Angeles, California, United States

St. Joseph Hospital

🇺🇸

Orange, California, United States

Medical Center of the Rockies

🇺🇸

Loveland, Colorado, United States

Medstar Washington Hospital Center

🇺🇸

Washington, District of Columbia, United States

University of Miami

🇺🇸

Miami, Florida, United States

Cleveland Clinic Florida

🇺🇸

Weston, Florida, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

Alexian Brothers Medical Center

🇺🇸

Elk Grove Village, Illinois, United States

Evanston Hospital/NorthShore Univ. Health System

🇺🇸

Evanston, Illinois, United States

Carle Foundation Hospital

🇺🇸

Urbana, Illinois, United States

Tufts Medical Center

🇺🇸

Boston, Massachusetts, United States

Maine Medical Center

🇺🇸

Portland, Maine, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Beaumont Hospital

🇺🇸

Royal Oak, Michigan, United States

Ascension St. Mary's Hospital

🇺🇸

Saginaw, Michigan, United States

Washington University in St. Louis

🇺🇸

Saint Louis, Missouri, United States

Morristown Memorial

🇺🇸

Morristown, New Jersey, United States

NYU Langone Medical Center

🇺🇸

New York, New York, United States

St. Francis Hospital

🇺🇸

Roslyn, New York, United States

Columbia University Medical Center/New York Presbyterian Hospital

🇺🇸

New York, New York, United States

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

UPMC Presbyterian

🇺🇸

Pittsburgh, Pennsylvania, United States

PinnacleHealth Cardiovascular Institute

🇺🇸

Wormleysburg, Pennsylvania, United States

WellSpan York Hospital

🇺🇸

York, Pennsylvania, United States

University of Vermont Medical Center

🇺🇸

Burlington, Vermont, United States

IHC Health Services, Inc. dba Intermountain Medical Center

🇺🇸

Murray, Utah, United States

St. Michael's Hospital

🇨🇦

Toronto, Ontario, Canada

University Medical Center Utrecht

🇳🇱

Utrecht, TH, Netherlands

Leiden University Medical Center

🇳🇱

Leiden, Netherlands

Erasmus Medical Center

🇳🇱

Rotterdam, Netherlands

Isala Clinics

🇳🇱

Zwolle, Netherlands

UCSF

🇺🇸

San Francisco, California, United States

Minneapolis Heart Institute

🇺🇸

Minneapolis, Minnesota, United States

Vanderbilt Heart and Vascular

🇺🇸

Nashville, Tennessee, United States

Mayo Clinic - Rochester

🇺🇸

Rochester, Minnesota, United States

University of Nebraska Medical Center

🇺🇸

Omaha, Nebraska, United States

Oregon Health Science University (OHSU)

🇺🇸

Portland, Oregon, United States

Oklahoma Heart Hospital

🇺🇸

Milwaukee, Wisconsin, United States

Advocate Aurora- St. Lukes

🇺🇸

Milwaukee, Wisconsin, United States

Medical College of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

Advocate Lutheran General Hospital

🇺🇸

Park Ridge, Illinois, United States

Swedish Medical Center

🇺🇸

Seattle, Washington, United States

Yale University

🇺🇸

New Haven, Connecticut, United States

Seton Medical Center Austin

🇺🇸

Austin, Texas, United States

Virginia Commonwealth University (VCU)

🇺🇸

Richmond, Virginia, United States

Rhode Island Hospital

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath